Overview A Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of TBA-354 in Healthy Adult Subjects Status: Completed Trial end date: 2015-06-01 Target enrollment: Participant gender: Summary The objective of this study is to evaluate the safety and tolerability of single oral doses of TBA-354 when administered to healthy adult subjects. Phase: Phase 1 Details Lead Sponsor: Global Alliance for TB Drug Development